These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12816082)

  • 1. Sequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel.
    Huang DD; Giesler TA; Bremer JW
    AIDS Res Hum Retroviruses; 2003 Apr; 19(4):321-8. PubMed ID: 12816082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.
    Pandrea I; Robertson DL; Onanga R; Gao F; Makuwa M; Ngari P; Bedjabaga I; Roques P; Simon F; Apetrei C
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1103-16. PubMed ID: 12396449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil.
    Rodrigues R; Scherer LC; Oliveira CM; Franco HM; Sperhacke RD; Ferreira JL; Castro SM; Stella IM; Brigido LF
    Virus Res; 2006 Mar; 116(1-2):201-7. PubMed ID: 16332398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults.
    Becker-Pergola G; Kataaha P; Johnston-Dow L; Fung S; Jackson JB; Eshleman SH
    AIDS Res Hum Retroviruses; 2000 May; 16(8):807-13. PubMed ID: 10826487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences.
    Balotta C; Facchi G; Violin M; Van Dooren S; Cozzi-Lepri A; Forbici F; Bertoli A; Riva C; Senese D; Caramello P; Carnevale G; Rizzardini G; Cremonini L; Monno L; Rezza G; Perno CF; Ippolito G; d'Arminio-Monforte A; Vandamme AM; Moroni M;
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):499-505. PubMed ID: 11511828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.
    Kantor R; Katzenstein D
    AIDS Rev; 2003; 5(1):25-35. PubMed ID: 12875105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
    de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland.
    Dehò L; Walwema R; Cappelletti A; Sukati H; Sibandze D; Almaviva M; Buttò S; Ensoli B; Galli M; Balotta C
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):323-5. PubMed ID: 18257688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
    Handema R; Terunuma H; Kasolo F; Kasai H; Sichone M; Yamashita A; Deng X; Mulundu G; Ichiyama K; Munkanta M; Yokota T; Wakasugi N; Tezuka F; Yamamoto N; Ito M
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):151-60. PubMed ID: 12643279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations.
    Deshpande A; Recordon-Pinson P; Deshmukh R; Faure M; Jauvin V; Garrigue I; Lafon ME; Fleury HJ
    AIDS Res Hum Retroviruses; 2004 Sep; 20(9):1032-5. PubMed ID: 15585093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV type 1 diversity in France, 1999-2001: molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs.
    Fleury H; Recordon-Pinson P; Caumont A; Faure M; Roques P; Plantier JC; Couturier E; Dormont D; Masquelier B; Simon F;
    AIDS Res Hum Retroviruses; 2003 Jan; 19(1):41-7. PubMed ID: 12596719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
    Servais J; Lambert C; Karita E; Vanhove D; Fischer A; Baurith T; Schmit JC; Schneider F; Hemmer R; Arendt V
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):279-83. PubMed ID: 15117451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.
    Descamps D; Delaugerre C; Masquelier B; Ruffault A; Marcelin AG; Izopet J; Chaix ML; Calvez V; Brun-Vézinet F; Costagliola D
    J Med Virol; 2006 Feb; 78(2):153-60. PubMed ID: 16372300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.
    Ríos M; Delgado E; Pérez-Alvarez L; Fernández J; Gálvez P; de Parga EV; Yung V; Thomson MM; Nájera R
    J Med Virol; 2007 Jun; 79(6):647-56. PubMed ID: 17457921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation of the protease and reverse transcriptase genes in HIV-1 CRF04_cpx strains.
    Papa A; Papadimitriou E; Papoutsi A; Malissiovas N; Kiosses VG; Antoniadis A
    AIDS Res Hum Retroviruses; 2002 Jun; 18(9):677-80. PubMed ID: 12079565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous nature of HIV-1 recombinants spreading in Spain.
    Holguín A; Alvarez A; Soriano V
    J Med Virol; 2005 Mar; 75(3):374-80. PubMed ID: 15648070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS; Cardoso LP; Stefani MM
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of hiv type 1 strains in bujumbura (burundi): predominance of subtype c variant.
    Koch N; Ndihokubwayo JB; Yahi N; Tourres C; Fantini J; Tamalet C
    AIDS Res Hum Retroviruses; 2001 Feb; 17(3):269-73. PubMed ID: 11177411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.